BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/7/2014 5:32:00 PM | Browse: 1509 | Download: 1573
 |
Received |
|
2014-02-16 21:11 |
 |
Peer-Review Started |
|
2014-02-16 21:32 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-03-31 10:14 |
 |
Revised |
|
2014-04-18 00:00 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-05-26 21:30 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-05-26 21:48 |
 |
Articles in Press |
|
2014-05-26 22:05 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-09-12 14:43 |
 |
Publish the Manuscript Online |
|
2014-10-07 17:32 |
| Category |
Pathology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Francesco Vasuri, Deborah Malvi, Francesca Rosini, Pamela Baldin, Michelangelo Fiorentino, Alexandro Paccapelo, Giorgio Ercolani, Antonio Daniele Pinna, Rita Golfieri, Antonio Maria Morselli-Labate, Walter Franco Grigioni and Antonia D’Errico-Grigioni |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Antonia D’Errico-Grigioni, MD, “F. Addarii” Institute of Oncology and Transplantation Pathology, S.Orsola-Malpighi Hospital, Bologna University, V.le Ercolani 4/2, 40138 Bologna, Italy. derrico@aosp.bo.it |
| Key Words |
Chemoembolization; Hepatocellular carcinoma; Histopathology; Orthotopic liver transplantation; Cancer recurrence; Transarterial chemoembolization |
| Core Tip |
Transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) is used for down-staging before orthotopic liver transplantation (OLT), and as “bridging therapy” to reduce the drop-out rates in the waiting list. A discrepancy exists between the pre-transplant (radiological) and post-transplant (pathological) staging. Few study analyzing the histology of TACE-treated HCC exist. Here we analyzed 11 histological variables in 275 nodules from 101 consecutive OLT recipients and we computed a histological score to stratify recipients into 3 risk groups, with 3.3%, 18.5% and 53.8% respectively of tumor recurrence rates. The histological score allows a better stratification of those recipients beyond the Milan criteria after OLT. |
| Publish Date |
2014-10-07 17:32 |
| Citation |
Vasuri F, Malvi D, Rosini F, Baldin P, Fiorentino M, Paccapelo A, Ercolani G, Pinna AD, Golfieri R, Morselli-Labate AM, Grigioni WF, D’Errico-Grigioni A. Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation. World J Gastroenterol 2014; 20(37): 13538-13545
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i37/13538.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i37.13538 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.